LENZ Therapeutics, Inc.
Extracted from this filing and checked against the source text.
LENZ Therapeutics, Inc. shareholders approved Election of the three director nominees to the Board as Class II directors to hold office until the 2026 Annual Meeting at the 2023-07-19 meeting.
Proposal 1 - Election of Directors The Company’s stockholders elected the three (3) director nominees below to the Company’s Board of Directors as Class II directors to hold office until the 2026 Annual Meeting of Stockholders of the Company or until their successors are duly elected and qualified.View on SEC.gov
LENZ Therapeutics, Inc. shareholders approved Ratification of Appointment of Independent Registered Accounting Firm Deloitte & Touche LLP at the 2023-07-19 meeting.
Proposal 2 - Ratification of Appointment of Independent Registered Accounting Firm The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2023.View on SEC.gov
215 shareholder votes filed in the last 30 days. Browse all shareholder votes →
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.